Cargando…
Human Health Effects of Dichloromethane: Key Findings and Scientific Issues
Background: The U.S. EPA’s Integrated Risk Information System (IRIS) completed an updated toxicological review of dichloromethane in November 2011. Objectives: In this commentary we summarize key results and issues of this review, including exposure sources, identification of potential health effect...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NLM-Export
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314245/ https://www.ncbi.nlm.nih.gov/pubmed/25325283 http://dx.doi.org/10.1289/ehp.1308030 |
_version_ | 1782355311151022080 |
---|---|
author | Schlosser, Paul M. Bale, Ambuja S. Gibbons, Catherine F. Wilkins, Amina Cooper, Glinda S. |
author_facet | Schlosser, Paul M. Bale, Ambuja S. Gibbons, Catherine F. Wilkins, Amina Cooper, Glinda S. |
author_sort | Schlosser, Paul M. |
collection | PubMed |
description | Background: The U.S. EPA’s Integrated Risk Information System (IRIS) completed an updated toxicological review of dichloromethane in November 2011. Objectives: In this commentary we summarize key results and issues of this review, including exposure sources, identification of potential health effects, and updated physiologically based pharmacokinetic (PBPK) modeling. Methods: We performed a comprehensive review of primary research studies and evaluation of PBPK models. Discussion: Hepatotoxicity was observed in oral and inhalation exposure studies in several studies in animals; neurological effects were also identified as a potential area of concern. Dichloromethane was classified as likely to be carcinogenic in humans based primarily on evidence of carcinogenicity at two sites (liver and lung) in male and female B6C3F(1) mice (inhalation exposure) and at one site (liver) in male B6C3F(1) mice (drinking-water exposure). Recent epidemiologic studies of dichloromethane (seven studies of hematopoietic cancers published since 2000) provide additional data raising concerns about associations with non-Hodgkin lymphoma and multiple myeloma. Although there are gaps in the database for dichloromethane genotoxicity (i.e., DNA adduct formation and gene mutations in target tissues in vivo), the positive DNA damage assays correlated with tissue and/or species availability of functional glutathione S-transferase (GST) metabolic activity, the key activation pathway for dichloromethane-induced cancer. Innovations in the IRIS assessment include estimation of cancer risk specifically for a presumed sensitive genotype (GST-theta-1+/+), and PBPK modeling accounting for human physiological distributions based on the expected distribution for all individuals 6 months to 80 years of age. Conclusion: The 2011 IRIS assessment of dichloromethane provides insights into the toxicity of a commonly used solvent. Citation: Schlosser PM, Bale AS, Gibbons CF, Wilkins A, Cooper GS. 2015. Human health effects of dichloromethane: key findings and scientific issues. Environ Health Perspect 123:114–119; http://dx.doi.org/10.1289/ehp.1308030 |
format | Online Article Text |
id | pubmed-4314245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | NLM-Export |
record_format | MEDLINE/PubMed |
spelling | pubmed-43142452015-02-06 Human Health Effects of Dichloromethane: Key Findings and Scientific Issues Schlosser, Paul M. Bale, Ambuja S. Gibbons, Catherine F. Wilkins, Amina Cooper, Glinda S. Environ Health Perspect Commentary Background: The U.S. EPA’s Integrated Risk Information System (IRIS) completed an updated toxicological review of dichloromethane in November 2011. Objectives: In this commentary we summarize key results and issues of this review, including exposure sources, identification of potential health effects, and updated physiologically based pharmacokinetic (PBPK) modeling. Methods: We performed a comprehensive review of primary research studies and evaluation of PBPK models. Discussion: Hepatotoxicity was observed in oral and inhalation exposure studies in several studies in animals; neurological effects were also identified as a potential area of concern. Dichloromethane was classified as likely to be carcinogenic in humans based primarily on evidence of carcinogenicity at two sites (liver and lung) in male and female B6C3F(1) mice (inhalation exposure) and at one site (liver) in male B6C3F(1) mice (drinking-water exposure). Recent epidemiologic studies of dichloromethane (seven studies of hematopoietic cancers published since 2000) provide additional data raising concerns about associations with non-Hodgkin lymphoma and multiple myeloma. Although there are gaps in the database for dichloromethane genotoxicity (i.e., DNA adduct formation and gene mutations in target tissues in vivo), the positive DNA damage assays correlated with tissue and/or species availability of functional glutathione S-transferase (GST) metabolic activity, the key activation pathway for dichloromethane-induced cancer. Innovations in the IRIS assessment include estimation of cancer risk specifically for a presumed sensitive genotype (GST-theta-1+/+), and PBPK modeling accounting for human physiological distributions based on the expected distribution for all individuals 6 months to 80 years of age. Conclusion: The 2011 IRIS assessment of dichloromethane provides insights into the toxicity of a commonly used solvent. Citation: Schlosser PM, Bale AS, Gibbons CF, Wilkins A, Cooper GS. 2015. Human health effects of dichloromethane: key findings and scientific issues. Environ Health Perspect 123:114–119; http://dx.doi.org/10.1289/ehp.1308030 NLM-Export 2014-10-17 2015-02 /pmc/articles/PMC4314245/ /pubmed/25325283 http://dx.doi.org/10.1289/ehp.1308030 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, “Reproduced with permission from Environmental Health Perspectives”); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Commentary Schlosser, Paul M. Bale, Ambuja S. Gibbons, Catherine F. Wilkins, Amina Cooper, Glinda S. Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title | Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title_full | Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title_fullStr | Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title_full_unstemmed | Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title_short | Human Health Effects of Dichloromethane: Key Findings and Scientific Issues |
title_sort | human health effects of dichloromethane: key findings and scientific issues |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314245/ https://www.ncbi.nlm.nih.gov/pubmed/25325283 http://dx.doi.org/10.1289/ehp.1308030 |
work_keys_str_mv | AT schlosserpaulm humanhealtheffectsofdichloromethanekeyfindingsandscientificissues AT baleambujas humanhealtheffectsofdichloromethanekeyfindingsandscientificissues AT gibbonscatherinef humanhealtheffectsofdichloromethanekeyfindingsandscientificissues AT wilkinsamina humanhealtheffectsofdichloromethanekeyfindingsandscientificissues AT cooperglindas humanhealtheffectsofdichloromethanekeyfindingsandscientificissues |